Pioneer in Interventional Cardiology

SIMON H.
STERTZER

Professor of Medicine, Emeritus, Stanford University

Division of Cardiovascular Medicine

Read Biography
icon Scientific Output

Scientific Output

150+

Peer-Reviewed Articles

50+

U.S. Patents

8+

Book Chapters

12+

Abstracts

Peer-Reviewed Articles

Foundational work in PTCA, stent technology, and
regenerative medicine ranging from the 1960s to present day.

Patents & Innovation

15+ U.S. Patents related to medical devices, catheters,
and drug delivery systems that revolutionized the industry.

A Legacy of Innovation

With a career spanning over 50 years, Dr. Simon H. Stertzer has been at the forefront of cardiovascular disease treatment. Recognized as the first to perform PTCA in the United States in 1978.

1957

Union College

AB, Phi Beta Kappa

1957

University of Paris

Certificate de Physiologie

1961

NYU Medical School

MD, Alpha Omega Alpha

1961–62

UC San Francisco

Internship

1962–67

NYU Residencies

Bellevue Hospital Chief Resident (1964)

1965–67

Cardiovascular Fellowship

NYU

Stanford Biodesign

Featured in the 2004 timeline, Stanford Biodesign highlights decades of pioneering work and the evolution of interventional cardiology at Stanford.

Illustrative reconstruction of physicians studying coronary angiography in a cardiac research laboratory

Commercial Impact

Ventures & Innovation

ADVISORY ↗

Avenda Health

Since the website was set up, I have become a member of the scientific advisory board of Avenda Health, a startup company in Los Angeles, designed to drastically…

LEARN MORE ⌄
PRIVATE ↗

Lumen Therapeutics

Lumen Therapeutics is a privately held, development stage biopharmaceutical company focused on proprietary drugs based on oligo-L-arginine.

LEARN MORE ⌄
PUBLIC ↗

CareDx®, Inc.

Founded in 1999 and now a public company, CareDx seeks to improve the quality of life of organ transplant patients through the use of non-invasive, diagonistic…

LEARN MORE ⌄
ACQUIRED ↗

Quanam Medical Corporation (acquired by Boston Scientific)

Founded in 1994, Quanam Medical Corporation developed polymer coated stents used for drug delivery in coronary angioplasty. It was acquired by Boston Scientific in 2001.

LEARN MORE ⌄
ACQUIRED ↗

Arterial Vascular Engineering (acquired by Medtronic, Inc.)

Acquired by Medtronic, Inc. in 1998, Arterial Vascular Engineering (AVE) developed coronary stents and balloon angioplasty catheters used to treat coronary artery disease.

LEARN MORE ⌄
ACTIVE ↗

BioCardia®, Inc.

More than 26 million people are living with heart failure worldwide, and between five and six million suffer from heart failure in the United States alone.…

LEARN MORE ⌄
philanthropic assistance icon

"Success in commercial application of scientific advances must be accompanied by philanthropic assistance”

Simon H. Stertzer, MD Chair icon

Stanford University

Simon H. Stertzer, MD Chair

Established in 1998 with a gift from Dr. Simon H. and Kimberly A. Stertzer, the professorship supports the position of the Chief of Interventional Cardiology at…

Biodesign Program icon

Stanford University

Biodesign Program

Funded fellowships and served as mentor to the Stanford Biodesign program, which advances innovation in cardiovascular technology.

Physicians Assistant Program icon

Stanford University

Physicians Assistant Program

Provides financial assistance to the Physicians Assistant program at Stanford University School of Medicine.

Latest Updates

Insights & News

Honors & Awards icon

Honors & Awards